A type of lymphocytes, regulatory T, help the cancer to survive instead of destroying it. Now it was discovered that a molecule called OX40 is able to make innocuiUna promising innovation for the immunotherapy of the future were defined as the results of the work published by Silvia Piconese the Department of Experimental Oncology National Cancer Institute of Milano.Utilizzare the patient's immune system against cancer, seen as a foreign agent to eliminate, is the basic principle of immunotherapy that has proved a useful tool for the treatment of various cancers. Despite the good results already obtained, there are still many obstacles to achieve full effectiveness of these therapies, the first of the complexity of the immune response and the interactions among many cell types that make up the system immunitario.Piconese and colleagues studied a particular type of cell, regulatory T lymphocytes (T reg), considered a major obstacle to successful immunotherapy.
Federico Cesareo
0 comments:
Post a Comment